VRIOLME ACT 40/5/12.5 TABLET
Generic Salt Composition: Olmesartan 40mg + Amlodipine 5mg + Chlorthalidone 12.5mg
Price: ₹42 MRP: ₹143.44
Save up to 71% compared to branded medicines.
Top Brand Substitutes & Equivalents
Olmesar-A-CH, Olvance-AMH, Olmy-Tri, Triolmesar, Olmetime-Tri, Amlopres-O-CH, Olmesar-Tri, Olmin-Tri, Tri-Olmesartan, Olmesartan-Amlodipine-Chlorthalidone, Oltri, Tri-Amlodipine, Olmesar-ACT, Olmesartan-Plus, Amlodipine-Chlorthalidone-Olmesartan, Olmetec-Tri, Olmesar-H-AM, Olmesartan-Combo, Tri-BP, Olmesar-Triple, Olmesartan Sun Pharma, Sun Pharma Olmesartan, Olmesartan Cipla, Cipla Olmesartan, Olmesartan Dr Reddys, Dr Reddys Olmesartan, Olmesartan Lupin, Lupin Olmesartan, Olmesartan Torrent, Torrent Olmesartan
Product Overview & Uses
VRIOLME ACT 40/5/12.5 TABLET is a potent, fixed-dose combination medication designed for the management of essential hypertension. As a key product in the Blood Pressure & Heart category, it integrates three distinct pharmacological mechanisms: Olmesartan medoxomil (an angiotensin II receptor blocker), Amlodipine besylate (a calcium channel blocker), and Chlorthalidone (a thiazide-like diuretic). This triple-action approach is specifically indicated for patients whose blood pressure is not adequately controlled by monotherapy or dual-combination therapy. By inhibiting the renin-angiotensin-aldosterone system, blocking calcium influx into vascular smooth muscle, and promoting natriuresis, VRIOLME ACT 40/5/12.5 TABLET provides comprehensive cardiovascular protection. Regular use as part of a structured treatment plan within the Blood Pressure & Heart category helps prevent long-term complications such as stroke, myocardial infarction, and renal impairment.